Cold Chain: Delivering Vaccines to Patients

This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Nov 15, 2017
Volume 2017 ebook, Issue 2, pg 46-49

With advancement in vaccine development comes an urgency to optimize the cold-chain delivery of these increasingly condition-sensitive biological products. This sensitivity has added new degrees of complexity to already complex supply chains and global regulations, resulting in the need for more precise approaches toward transporting vaccines. 

Read this article from Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017 eBook.

View other articles in Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017 eBook.  

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 46–49

Citation

When referring to this article, please cite it as A. Lowry, " Cold Chain: Delivering Vaccines to Patients," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

native1_300x100
lorem ipsum